Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > LET SEDI BE YOUR GUIDING LIGHT

<< Previous

Bullboard Posts

Next >>

Comment by CamaroZL1on Jan 22, 2021 8:10am

47 Views

Post# 32357593

RE:RE:RE:RE:RE: LET SEDI BE YOUR GUIDING LIGHT

I like to hear the other side of the trade. Its like confirmation. same old rhetoric each time no matter where you go. "I warned you, lotto ticket, turd, etc," lol we are all big boys and girls, this is penny stock speculation, people are well aware. This odds with VXL are way better than lotto, they are certainly not 86M to 1.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects